Cimarron Healthcare Capital Fund II-B, LP — Form D/A
Cimarron Healthcare Capital Fund II-B, LP of SALT LAKE CITY, UT, a pooled investment fund, filed a Form D amendment with the SEC on 2023-02-06. $118.7M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2023-02-06
- Form: D/A
- Accession: 0001840208-23-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1, 3C.7
- Amount sold: $118.7M
- Investors: 114
- Date of first sale: 2021-10-18
- Security types: equity, fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-429910
Issuer
- Name: Cimarron Healthcare Capital Fund II-B, LP
- CIK: 0001840210
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 6440 S WASATCH BLVD, SUITE 380, SALT LAKE CITY, UT, 84121
- Phone: 801-849-9293
Officers, directors & promoters (1)
| Name | Role | Location |
|---|
| James Nadauld | Executive Officer | SAN FRANCISCO, CA |
Other filings by this issuer (1)
More